CAMBRIDGE, Mass.--(BUSINESS WIRE)--Phase One patient data from a potential therapy targeting a single KRAS mutation, formerly considered “undruggable,” has been introduced in 2019. Now, Elicio ...
Researchers have developed a fast and cost-effective method to test liquids for a ubiquitous family of chemical compounds known as amphiphiles, which are used to detect diseases such as early-stage ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Elicio Therapeutics, a private biotechnology company developing a pipeline of potent immunotherapies based on its proprietary lymph node targeting technology, ...
Research conducted at the Irvine Lab at the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology is being utilized in Elicio's AMP-CAR-T Platform Activation of ...
Researchers from the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) have developed a fast and cost-effective method to test liquids for a ubiquitous family of chemical ...
Researchers from the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) have developed a fast and cost-effective method to test liquids for a ubiquitous family of chemical ...
However, when the protein–ligand part of the amphiphile is bound to the protein, the aggregate is disassembled, resulting in a sharp 19 F NMR signal. Interestingly, the system is reversible, and when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results